Newly generated monoclonal antibodies effective against SARS-CoV-2 and variants
Japanese researchers have successfully produced potent neutralizing monoclonal antibodies from a patient who recovered rapidly from a severe case of
Read moreJapanese researchers have successfully produced potent neutralizing monoclonal antibodies from a patient who recovered rapidly from a severe case of
Read moreResults from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib
Read moreCardiovascular disease, the most common cause of death, is the result of oxygen deprivation as blood perfusion to affected tissue
Read moreCystic fibrosis is the most frequent severe inherited disorder worldwide. Every year, hundreds of families are confronted with this diagnosis—and
Read moreMillions of people around the world use proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at
Read more